Bert believes in improving healthcare through the use of precision medicine, genetics and genomics. Bert has been a pioneer in laboratory robotics, technology development and gene mapping. Bert is a board-certified clinical molecular geneticist and a well-known cancer biologist. Bert holds a PhD from Tufts University and completed postdoctoral studies at Harvard & UCSF. Bert was a Staff Scientist at the National Cancer Institute of NIH for 15 years.